Issue

Vol. 63 No. 11: Issue 11

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

A meta-analysis study of the association between EGFR rs2252586 mutation and the risk of glioma

https://doi.org/10.14715/cmb/2017.63.11.20
Ye Xin
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China
Fu-Gang Han
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China
Dong Chen
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China
Jing Chen
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China
Chun-Xia Fang
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China
Li Lou
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China
Han Liu
Department of Radiology, The affiliated hospital of south west medical university, Luzhou 646000, Sichuan, China

Corresponding Author(s) : Ye Xin

huanghuai86xiana@163.com

Cellular and Molecular Biology, Vol. 63 No. 11: Issue 11

Abstract

Several studies reported the association between Epidermal growth factor receptor (EGFR) rs2252586 mutation and glioma susceptibility. However, the results of these studies were inconsistent. A computer-based search using EMBASE and PubMed databases was conducted. Odds ratios (OR) and 95% confidence interval (CI) were used to assess the strength of association between EGFR rs2252586 mutation and glioma susceptibility. The EGFR rs2252586 mutation was significantly associated with an increased risk of glioma (OR=1.16; 95%CI, 1.11–1.21; P<0.00001). When stratified by tumor subtype, the significantly elevated risk was observed in glioblastoma (OR=1.15; 95%CI, 1.04–1.26; P=0.007) but not in oligodendroglioma (OR=1.19; 95%CI, 0.97–1.46; P=0.10). When we excluded the studies with small sample size (case number < 1000), a significant association between EGFR rs2252586 mutation and glioma susceptibility remained (OR=1.16; 95%CI, 1.09–1.22; P<0.00001). In conclusion, this meta-analysis found that EGFR rs2252586 mutation was significantly associated with glioma risk.

Keywords

Glioma EGFR Genetic.
Xin, Y., Han, F.-G., Chen, D., Chen, J., Fang, C.-X., Lou, L., & Liu, H. (2017). A meta-analysis study of the association between EGFR rs2252586 mutation and the risk of glioma. Cellular and Molecular Biology, 63(11), 116–118. https://doi.org/10.14715/cmb/2017.63.11.20
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014;15(7):455-65.
  2. Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia. 2010;12(9):675–84.
  3. Furnari FB, Cloughesy TF, Cavenee WK, Mischel PS. Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma. Nat Rev Cancer. 2015;15(5):302-10.
  4. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, Enciso-Mora V, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Boisselier B, Carpentier C, Wang XW, Di Stefano AL, Labussière M, Gousias K, Schramm J, Boland A, Lechner D, Gut I, Armstrong G, Liu Y, Yu R, Lau C, Di Bernardo MC, Robertson LB, Muir K, Hepworth S, Swerdlow A, Schoemaker MJ, Wichmann HE, Müller M, Schreiber S, Franke A, Moebus S, Eisele L, Försti A, Hemminki K, Lathrop M, Bondy M, Houlston RS, Simon M. Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet. 2011;20(14):2897-904.
  5. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, Buring JE, Butler MA, Braganza M, Carreon T, Feychting M, Fleming SJ, Gapstur SM, Gaziano JM, Giles GG, Hallmans G, Henriksson R, Hoffman-Bolton J, Inskip PD, Johansen C, Kitahara CM, Lathrop M, Liu C, Le Marchand L, Linet MS, Lonn S, Peters U, Purdue MP, Rothman N, Ruder AM, Sanson M, Sesso HD, Severi G, Shu XO, Simon M, Stampfer M, Stevens VL, Visvanathan K, White E, Wolk A, Zeleniuch-Jacquotte A, Zheng W, Decker P, Enciso-Mora V, Fridley B, Gao YT, Kosel M, Lachance DH, Lau C, Rice T, Swerdlow A, Wiemels JL, Wiencke JK, Shete S, Xiang YB, Xiao Y, Hoover RN, Fraumeni JF Jr, Chatterjee N, Hartge P, Chanock SJ. Genome-wide association study of glioma and meta-analysis. Hum Genet. 2012;131(12):1877-88.
  6. Melin B, Dahlin AM, Andersson U, Wang Z, Henriksson R, Hallmans G, Bondy ML, Johansen C, Feychting M, Ahlbom A, Kitahara CM, Wang SS, Ruder AM, Carreón T, Butler MA, Inskip PD, Purdue M, Hsing AW, Mechanic L, Gillanders E, Yeager M, Linet M, Chanock SJ, Hartge P, Rajaraman P. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study. Int J Cancer. 2013;132(10):2464-8.
  7. Di Stefano AL, Enciso-Mora V, Marie Y, Desestret V, Labussière M, Boisselier B, Mokhtari K, Idbaih A, Hoang-Xuan K, Delattre JY, Houlston RS, Sanson M. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Neuro Oncol. 2013;15(5):542-7.
  8. Wibom C, Späth F, Dahlin AM, Langseth H, Hovig E, Rajaraman P, Johannesen TB, Andersson U, Melin B. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev. 2015;24(5):810-6.
  9. Cioca A, Olteanu EG, Gisca MD, Morosanu CO, Marin I, Florian IS. Expression of EGFR in Paired New and Recurrent Glioblastomas. Asian Pac J Cancer Prev. 2016;17(9):4205-4208.
  10. Wang FY, Kang CS, Wang-Gou SY, Huang CH, Feng CY, Li XJ. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma. Cancer Lett. 2017;384:9-18.
  11. Li B, Zhao W, Li J, Yan M, Xie Z, Zhu Y, Chen C, Jin T. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients. Oncotarget. 2016;7(39):63054-63064.
  12. Tsuchihashi K, Okazaki S, Ohmura M, Ishikawa M, Sampetrean O, Onishi N, Wakimoto H, Yoshikawa M, Seishima R, Iwasaki Y, Morikawa T, Abe S, Takao A, Shimizu M, Masuko T, Nagane M, Furnari FB, Akiyama T, Suematsu M, Baba E, Akashi K, Saya H, Nagano O. The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-).Cancer Res. 2016;76(10):2954-63.
  13. Phoa AF, Browne S, Gurgis FM, í…kerfeldt MC, Döbber A, Renn C, Peifer C, Stringer BW, Day BW, Wong C, Chircop M, Johns TG, Kassiou M, Munoz L. Pharmacology of novel small-molecule tubulin inhibitors in glioblastoma cells with enhanced EGFR signalling. Biochem Pharmacol. 2015;98(4):587-601.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 859 Download : 346

Most read articles by the same author(s)